In vitro evaluation of ^99m Tc-sultamicillin for infection imaging

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Chemistry
• Infectious Disease Imaging

Background:

• Non-invasive detection of infection sites using radiolabeled molecules is crucial for effective treatment.
• Technetium-99m (99mTc) labeled antibiotics offer potential for differentiating bacterial infections from sterile inflammation.

Purpose of the Study:

• To radiolabel sultamicillin with 99mTc using the stannous chloride method.
• To evaluate the in vitro characteristics and bacterial uptake of 99mTc-sultamicillin.

Main Methods:

• Sultamicillin was labeled with 99mTc via the stannous chloride method.
• Quality control was performed using radiochromatographic techniques.
• In vitro binding assays were conducted with live and heat-killed Staphylococcus aureus and Escherichia coli.

Main Results:

• The radiolabeling yield for 99mTc-sultamicillin was high, at 97.8% ± 3.1%.
• Significant bacterial uptake was observed: 80.7% ± 11.00% for S. aureus at 4 hours and 93.2% ± 4.40% for E. coli at 2 hours.
• These results indicate effective binding to both gram-positive and gram-negative bacteria.

Conclusions:

• 99mTc-sultamicillin demonstrates potential as a nuclear imaging agent for infection detection.
• Its efficacy is particularly noted for infections caused by gram-negative Escherichia coli and gram-positive Staphylococcus aureus.